Bruce R. Moon, David W. Selby, and Russ Somma Win ISPE Awards
International Society for Pharmaceutical Engineering (ISPE, Tampa, FL), a global not-for-profit association of 25,000 pharmaceutical science and manufacturing professionals, has announced its 2007 award winners.
International Society for Pharmaceutical Engineering (ISPE, Tampa, FL), a global not-for-profit association of 25,000 pharmaceutical science and manufacturing professionals, has announced its 2007 award winners. Robert P. Best, ISPE’s president and CEO, presented the honors at the Society’s 2007 Annual Meeting in Las Vegas, NV.
Bruce R. Moon received the Richard B. Purdy Distinguished Achievement Award. This award honors an ISPE member who has made significant, long-term contributions to the society.
David W. Selby, PhD, received the Professional Achievement Award, which honors an ISPE member who has made a significant contribution, not only to ISPE, but also to the pharmaceutical manufacturing industry.
Russ Somma, PhD, won the Max Seales Yonker Member of the Year Award, which honors the ISPE member who has made the most significant contribution to the society during the past year.
Complete list of winners
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
May 14th 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
